I just posted it as a FYI, that is my agenda, now I will go back to lurking, info pasted below. There reason is strange as they bought it a lot higher and never told their subscribers to sell till after it had rebounded off it`s low. Greg
TapImmune (OTCBB: TPIV) has a promising drug that has the potential to beat cancer someday.
Yet, despite favorable clinical trial results and a great mention on television, the stock has failed to gain much traction.
Clinical trials can be a long endeavor. This company could literally be working this through the FDA for years to come. And in the meantime, every time it runs out of money, it will be looking to shareholders to help sustain it.
While we love TapImmune, and its breakthrough treatment, we simply can’t hold onto this company for years and hope that its drug works out.
So here’s what I want you to do…
Sell your shares of TapImmune (OTCBB: TPIV) immediately.
James and I will keep our eye on this stock. If we feel a better time to buy has come, we’ll let you know.
Take care,
Charles Del Valle
News 
Market Data 
Discover 
